Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lucie, Čermáková"'
Autor:
Lucie Čermáková, Jakub Hofman, Lenka Laštovičková, Lucie Havlíčková, Ivona Špringrová, Eva Novotná, Vladimír Wsól
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 1994 (2022)
Zanubrutinib (ZAN) is a Bruton’s tyrosine kinase inhibitor recently approved for the treatment of some non-Hodgkin lymphomas. In clinical trials, ZAN is often combined with standard anthracycline (ANT) chemotherapy. Although ANTs are generally effe
Externí odkaz:
https://doaj.org/article/31ed61bcf4dc435d95e61ac1024078be
Autor:
Iva, Dolinová, Jana, Prattingerová, Pavel, Kočí, Martin, Kracík, Tomáš, Zajíc, Kateřina, Štillerová, Kateřina, Arientová, Sebastian Cristian, Treitli, Helena, Jiřincová, Magdalena, Ceé, Lucie, Čermáková, Vladimír, Valenta, Tereza, Kopecká, Tomáš, Jirásek
Publikováno v:
Casopis lekaru ceskych. 161(1)
Shortly after the WHOs first notice a suspected case of omicron SARS-CoV-2 was reported in Liberec, Czech Republic. The primary goal of the following actions was to test the presence of the variant and stop the spread of the virus variant. On Novembe
Autor:
Lucie Čermáková
Publikováno v:
Gardens and Landscapes of Portugal. 6:20-36
The article investigates Renaissance naturalists’ views on the links between plants and places where they grow. It looks at the Renaissance culture of botanical excursions and observation of plants in their natural environment and analyses the meth
Autor:
Wsól, Anselm Morell, Lucie Čermáková, Eva Novotná, Lenka Laštovičková, Melodie Haddad, Andrew Haddad, Ramon Portillo, Vladimír
Publikováno v:
Cancers; Volume 12; Issue 12; Pages: 3731
Over the last few years, aldo-keto reductase family 1 member C3 (AKR1C3) has been associated with the emergence of multidrug resistance (MDR), thereby hindering chemotherapy against cancer. In particular, impaired efficacy of the gold standards of in
Autor:
Anselm Morell, Lucie Čermáková, Eva Novotná, Lenka Laštovičková, Melodie Haddad, Andrew Haddad, Ramon Portillo, Vladimír Wsól
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3731, p 3731 (2020)
Cancers, Vol 12, Iss 3731, p 3731 (2020)
Simple Summary The enzyme aldo-keto reductase 1C3 (AKR1C3) is present in several cancers, in which it is capable of actively metabolising different chemotherapy drugs and decreasing their cytotoxic effects. Therefore, the combination with specific in
Autor:
Lucie Čermáková
Publikováno v:
Early Science and Medicine. 23:487-508
During the sixteenth and seventeenth centuries, plants were the object of a primarily descriptive approach: naturalists were concerned mainly with collecting and classifying. When confronted with the splendour of great herbals and florilegia, one can
Autor:
Petr Solich, Anselm Morell, Neslihan Büküm, Eva Novotná, Ramon Portillo, Vladimír Wsól, Lucie Čermáková, Jana Želazková, Lenka Laštovičková
Publikováno v:
Biochemical Pharmacology. 192:114710
Bcr-Abl tyrosine kinase inhibitors significantly improved Philadelphia chromosome-positive leukaemia therapy. Apart from Bcr-Abl kinase, imatinib, dasatinib, nilotinib, bosutinib and ponatinib are known to have additional off-target effects that migh